From: Time to achieve remission determines time to be in remission
Variable and range of values | Patients included |
---|---|
Age (mean [SD], years) | 54 [14] |
Women (n [%]) | 477 [63%] |
Rheumatoid factor positive (n [%]) | 578 [77%] |
Disease duration (median [IQR], weeks) | 0 [0-4] |
DAS (mean [SD]) | 3.98 [1.28] |
DAS28 (mean [SD]) | 5.07 [1.32] |
HAQ score (median [IQR]) | 0.63 [0.25-1.19] |
ESR (median [IQR], mm/h) | 29 [16-48] |
CRP (median [IQR], mg/L) | 12 [1.7-37] |
44 swollen joint count (median [IQR]) | 13 [8-18] |
53 tender joint count (median [IQR]) | 10 [5-17] |
VAS pain, 0-100 (mean [SD], mm) | 44 [23] |
Patient's global assessment, 0-100 (mean [SD], mm) | 46 [24] |
VAS GH, 0-100 (mean [SD], mm) | 44 [22] |
Physicians global assessment, 0-100 (mean [SD], mm) | 34 [18] |
Morning stiffness (median [IQR], min) | 30 [0-90] |